Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0B1MJ
|
|||
Former ID |
DIB009539
|
|||
Drug Name |
Dexniguldipine
|
|||
Synonyms |
Dexniguldipine hydrochloride; BY-935; B-8509-035; B-859-35
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Discontinued in Phase 2 | [1], [2] | |
Company |
ALTANA Pharma AG
|
|||
Structure |
Download2D MOL |
|||
Formula |
C36H39N3O6
|
|||
Canonical SMILES |
CC1=C(C(C(=C(N1)C)C(=O)OCCCN2CCC(CC2)(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC(=CC=C5)[N+](=O)[O-])C(=O)OC
|
|||
InChI |
1S/C36H39N3O6/c1-25-31(34(40)44-3)33(27-12-10-17-30(24-27)39(42)43)32(26(2)37-25)35(41)45-23-11-20-38-21-18-36(19-22-38,28-13-6-4-7-14-28)29-15-8-5-9-16-29/h4-10,12-17,24,33,37H,11,18-23H2,1-3H3/t33-/m1/s1
|
|||
InChIKey |
SVJMLYUFVDMUHP-MGBGTMOVSA-N
|
|||
CAS Number |
CAS 120054-86-6
|
|||
PubChem Compound ID | ||||
PubChem Substance ID | ||||
ChEBI ID |
CHEBI:103932
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Multidrug resistance protein 3 (ABCB4) | Target Info | Modulator | [3] |
KEGG Pathway | ABC transporters | |||
Bile secretion | ||||
Reactome | PPARA activates gene expression | |||
ABC-family proteins mediated transport | ||||
WikiPathways | Nuclear Receptors in Lipid Metabolism and Toxicity | |||
Farnesoid X Receptor Pathway | ||||
Regulation of Lipid Metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha) |
References | Top | |||
---|---|---|---|---|
REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 463). | |||
REF 2 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800002528) | |||
REF 3 | Mechanism of action of dexniguldipine-HCl (B8509-035), a new potent modulator of multidrug resistance. Biochem Pharmacol. 1995 Mar 1;49(5):603-9. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.